Breakthrough Cancer Pain
medical animation

MoA video for a U.S. product launch of a breakthrough oncology drug.

Description

This 3D mechanism-of-action animation has been created for the U.S. product launch of Abstral® (fentanyl) Sublingual Tablets, the treatment for Breakthrough Cancer Pain (BTcP).

We began the video with the introduction of the cause of pain; highlighting metastatic bone cancer, before showcasing the mechanism of action (MOA) of the drug and its significant effect on breakthrough cancer pain.

Deliverables

3D animation

product shots

high resolution images

Brand

Abstral®

Client

Galena Biopharma


The video is fantastic! It looks great! We appreciate the effort to get this in time for our conference.

— Galena Biopharma | Oregon, USA

breakthrough cancer pain animation

What is Breakthrough Cancer Pain

1Breakthrough cancer pain (BTcP) is defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.

Breakthrough cancer pain occurs in the majority of patients who are already receiving chronic, long-acting opioid pain management and yet have episodes of severe tumor- and treatment-related cancer pain.

reference: 1galenabiopharma.com

Related Work

Need Help With A Project?

Get in touch